Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human (331) Apply Human filter Veterinary (1) Apply Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Summaries of opinion Remove Summaries of opinion filter Withdrawn applications Remove Withdrawn applications filter Paediatric investigation plans Remove Paediatric investigation plans filter Orphan designations Remove Orphan designations filter Direct healthcare professional communication Remove Direct healthcare professional communication filter European public assessment reports (EPAR) (419) Apply European public assessment reports (EPAR) filter Referrals (17) Apply Referrals filter

Product number

Opinion status

Positive (22) Apply Positive filter

Application type

Initial authorisation (7) Apply Initial authorisation filter Post-authorisation (15) Apply Post-authorisation filter

Date of opinion

From:

To:

Withdrawal type

Initial authorisation (3) Apply Initial authorisation filter Post-authorisation (11) Apply Post-authorisation filter

Withdrawal date

From:

To:

PIP decision type

P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) (18) Apply P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) filter PM: decision on the application for modification of an agreed PIP (130) Apply PM: decision on the application for modification of an agreed PIP filter RPM: decision refers to a refusal on the application for modification of an agreed PIP (1) Apply RPM: decision refers to a refusal on the application for modification of an agreed PIP filter RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) (1) Apply RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) filter W: decision granting a waiver in all age groups for all conditions or indications (28) Apply W: decision granting a waiver in all age groups for all conditions or indications filter

PIP condition / indication

Pharmaceutical form(s)

Route(s) of administration

Decision date

From:

To:

PIP compliance check

Yes (16) Apply Yes filter

Compliance procedure number

Orphan disease / condition

Orphan decision number

Orphan designation status

Positive (109) Apply Positive filter

ATC code

Medicine type

Accelerated assessment Remove Accelerated assessment filter Additional monitoring Remove Additional monitoring filter Biosimilar Remove Biosimilar filter Conditional approval Remove Conditional approval filter Exceptional circumstances Remove Exceptional circumstances filter Generic (30) Apply Generic filter Orphan medicine (336) Apply Orphan medicine filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

332 results

Remove all filtersRemove all filters

Medicine type Accelerated assessment Remove Accelerated assessment filter Additional monitoring Remove Additional monitoring filter Exceptional circumstances Remove Exceptional circumstances filter Biosimilar Remove Biosimilar filter Conditional approval Remove Conditional approval filter

Medicine Orphan designations Remove Orphan designations filter Withdrawn applications Remove Withdrawn applications filter Direct healthcare professional communication Remove Direct healthcare professional communication filter Paediatric investigation plans Remove Paediatric investigation plans filter Summaries of opinion Remove Summaries of opinion filter

Sort by

List item

Summary of opinion: Bluevac BTV (previously known as Bluevac BTV8)

opinion date: 18/06/2020, Positive, Last updated: 19/06/2020
List item

Summary of opinion: Tecartus

opinion date: 15/10/2020, Positive, Last updated: 16/10/2020
List item

Summary of opinion: Blincyto

blinatumomab, opinion date: 15/10/2020, Positive, Last updated: 16/10/2020
List item

Summary of opinion: Onbevzi

bevacizumab, opinion date: 12/11/2020, Positive, Last updated: 13/11/2020
List item

Summary of opinion: Xarelto

rivaroxaban, opinion date: 12/11/2020, Positive, Last updated: 13/11/2020
List item

Summary of opinion: Symkevi

tezacaftor, ivacaftor, opinion date: 17/09/2020, Positive, Last updated: 18/09/2020
List item

Summary of opinion: Dupixent

dupilumab, opinion date: 15/10/2020, Positive, Last updated: 16/10/2020
List item

Summary of opinion: Kyprolis

carfilzomib, opinion date: 12/11/2020, Positive, Last updated: 13/11/2020
List item

Summary of opinion: Tremfya

guselkumab, opinion date: 15/10/2020, Positive, Last updated: 16/10/2020
List item

Summary of opinion: Retsevmo

selpercatinib, opinion date: 10/12/2020, Positive, Last updated: 11/12/2020
List item

Summary of opinion: Bavencio

avelumab, opinion date: 10/12/2020, Positive, Last updated: 11/12/2020
List item

Summary of opinion: Doptelet

avatrombopag, opinion date: 10/12/2020, Positive, Last updated: 11/12/2020
List item

Summary of opinion: Spravato

esketamine, opinion date: 10/12/2020, Positive, Last updated: 11/12/2020
List item

Summary of opinion: Kixelle

insulin aspart, opinion date: 10/12/2020, Positive, Last updated: 11/12/2020
List item

Summary of opinion: Yuflyma

adalimumab, opinion date: 10/12/2020, Positive, Last updated: 11/12/2020
List item

Summary of opinion: Enhertu

trastuzumab deruxtecan, opinion date: 10/12/2020, Positive, Last updated: 11/12/2020
List item

Summary of opinion: Tecentriq

atezolizumab, opinion date: 17/09/2020, Positive, Last updated: 18/09/2020
List item

Summary of opinion: Kalydeco

ivacaftor, opinion date: 17/09/2020, Positive, Last updated: 18/09/2020
List item

Summary of opinion: Keytruda

pembrolizumab, opinion date: 10/12/2020, Positive, Last updated: 11/12/2020
List item

Summary of opinion: Rinvoq

upadacitinib, opinion date: 10/12/2020, Positive, Last updated: 11/12/2020
List item

Summary of opinion: COVID-19 Vaccine Moderna

COVID-19 mRNA Vaccine (nucleoside modified), opinion date: 06/01/2021, Positive, Last updated: 06/01/2021
List item

Summary of opinion: Recarbrio

imipenem, cilastatin, relebactam, opinion date: 15/10/2020, Positive, Last updated: 16/10/2020
List item

Withdrawn application: Keytruda

pembrolizumab, date of withdrawal: 10/12/2019, Post-authorisation, Last updated: 19/03/2020
List item

Withdrawn application: Zydelig

idelalisib, date of withdrawal: 30/01/2018, Post-authorisation, Last updated: 23/02/2018
List item

Withdrawn application: Keytruda

pembrolizumab, date of withdrawal: 11/10/2017, Post-authorisation, Last updated: 28/11/2017

Load more

332 results

Summary of opinion: Bluevac BTV (previously known as Bluevac BTV8)

Summary of opinion: Tecartus

Summary of opinion: Blincyto

Summary of opinion: Onbevzi

Summary of opinion: Xarelto

Summary of opinion: Symkevi

Summary of opinion: Dupixent

Summary of opinion: Kyprolis

Summary of opinion: Tremfya

Summary of opinion: Retsevmo

Summary of opinion: Bavencio

Summary of opinion: Doptelet

Summary of opinion: Spravato

Summary of opinion: Kixelle

Summary of opinion: Yuflyma

Summary of opinion: Enhertu

Summary of opinion: Tecentriq

Summary of opinion: Kalydeco

Summary of opinion: Keytruda

Summary of opinion: Rinvoq

Summary of opinion: COVID-19 Vaccine Moderna

Summary of opinion: Recarbrio

Withdrawn application: Keytruda

Withdrawn application: Zydelig

Withdrawn application: Keytruda